ArticleJournal of Korean medical science2023

Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant.

Beomki Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.